REFERENCES
- Dodds E M. Ocular toxoplasmosis: Clinical presentation, diagnosis and therapy. Focal Points: Clinical Modules for Ophthalmologists. American Academy of Ophthalmology, San Francisco 1999; Vol. 17: 10
- Holland G N, O'Connor G R, Belfort R, Remington J S. Toxoplasmosis. Ocular Infection & Immunity, J S People, G N Holland, K R Wilhelmus. Mosby-Year Book, St. Louis, MO 1996; 1083–1223
- Dodds E M. Toxoplasmosis. Curr Opin Ophthalmol 2006; 17: 557–561
- Rothova A, Bosch-Driessen L E, van Loon N H, Treffers W F. Azithromycin for ocular toxoplasmosis. Br J Ophthalmol 1998; 82: 1306–1308
- Rothova A, Meenken C, Buitenhuis H J, et al. Therapy for ocular toxoplasmosis. Am J Ophthalmol. 1993; 115: 517–523
- Opremcak E M, Scales D K, Sharpe M R. Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis. Ophthalmology 1992; 99: 920–925
- Huskinson-Mark J, Araujo F G, Remington J S. Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. J Infect Dis 1991; 164: 170–171
- Silveira C, Belfort R, Jr, Muccioli C, et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 2002; 134: 41–46
- McCannel C A, Holland G N, Helm C J, Cornell P J, Winston J V, Rimmer T G. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol 1996; 121: 35–46
- Soheilian M, Heidari K, Yazdani S, Shahsavari M, Ahmadieh H, Dehghan M. Patterns of uveitis in a tertiary eye care center in Iran. Ocul Immunol Inflamm 2004; 12: 297–310
- Holland G N, Lewis K G. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 2002; 134: 102–114
- Acers T E. Toxoplasmic retinochoroiditis: a double blind therapeutic study. Arch Ophthalmol 1964; 71: 58–62
- Stanford M R, See S E, Jones L V, Gilbert R E. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review. Ophthalmology 2003; 110: 926–931
- Bosch-Driessen L E, Berendschot T T, Ongkosuwito J V, Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 2002; 109: 869–878
- Bosch-Driessen L H, Verbraak F D, Suttorp-Schulten M SA, et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. Am J Ophthalmol. 2002; 134: 34–40
- Katlama C, De Wit S, O'Doherty E, Van Glabeke M, Clumeck N. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis 1996; 22: 268–275